Standards of care for Kasabach-Merritt phenomenon in China

Wei Yao1, Ke-Lei Li2, Zhong-Ping Qin3

  • 1Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai, 201102, China.

Insights

Kasabach-Merritt phenomenon (KMP) is a rare pediatric condition causing severe low platelets and clotting issues. This review provides standardized Chinese clinical practice recommendations for KMP management.

Area of Science:

  • Pediatric Hematology
  • Vascular Anomalies

Background:

  • Kasabach-Merritt phenomenon (KMP) is a rare, life-threatening condition in infants and children.
  • Characterized by severe thrombocytopenia and consumptive coagulopathy.
  • Associated with specific vascular tumors: kaposiform hemangioendothelioma and tufted hemangioma.

Purpose of the Study:

  • To establish standardized recommendations for KMP diagnosis and treatment in China.
  • To provide a clinical practice reference for healthcare professionals.
  • To improve the management of KMP based on current evidence.

Main Methods:

  • Comprehensive literature review.
  • Synthesis of existing research on KMP pathogenesis, clinical features, and treatment.
  • Development of consensus-based guidelines for the Chinese context.

Main Results:

  • Detailed overview of KMP pathogenesis and etiology.
  • Description of typical clinical manifestations and diagnostic criteria.
  • Standardized treatment protocols including medical and surgical interventions.

Conclusions:

  • Standardized recommendations are crucial for effective KMP management.
  • Early diagnosis and prompt, multidisciplinary treatment improve patient outcomes.
  • These guidelines offer a valuable reference for clinical practice in China and potentially beyond.

Related Concept Videos